Boothbay Fund Management »

Traws Pharma shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Traws Pharma (TRAW) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Traws Pharma

Tip: Access up to 7 years of quarterly data

All positions including Traws Pharma held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Traws Pharma by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $220k 195k 1.13
2025-03-31 $77k 33k 2.30
2024-12-31 $108k 28k 3.80

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Traws Pharma

Ikarian Capital
OrbiMed Advisors
Adage Capital Partners GP
Boothbay Fund Management
ADAR1 Capital Management
Vanguard Group
Geode Capital Management
Seven Fleet Capital Management
XTX Topco
State Street Corporation
Two Sigma Investments
Susquehanna International
BlackRock
UBS Group
SBI Securities

View all funds holding Traws Pharma